Search

The article presents information on a study that analyzed the effectiveness of oxcarbazepine in the treatment of children and adolescents with bipolar I disorder(BP-I). The manic symptoms between oxcarbazepine and placebo were found to be the same. It was concluded that oxcarbazepine increases adverse events and does not improve BP-I manic symptoms as compared with placebo.

The article presents a study on the validity of Mood Disorder Questionnaire (MDQ) for adolescents as a screening instrument for bipolar disorder in psychiatric outpatient clinics. It discusses the design method used, the clinical setting, number of patients, test questionnaire, diagnostic standard and outcomes. The results shows that the parental report version of the MDQ provides a better sensitivity for diagnosis of bipolar disorders than self report in outpatient clinics.